MCM
MRNA icon

MV Capital Management’s Moderna MRNA Stock Holding History

MV Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.68K Buy
124
+5
+4% +$259 ﹤0.01% 562
2026
Q1 		$6.05K Buy
119
+1
+0.8% +$47 ﹤0.01% 589
2025
Q4 		$3.48K Sell
118
-80
-40% -$2.17K ﹤0.01% 650
2025
Q3 		$5.12K Sell
198
-116
-37% -$3.24K ﹤0.01% 600
2025
Q2 		$8.66K Buy
314
+145
+86% +$3.82K ﹤0.01% 543
2025
Q1 		$4.79K Buy
169
+40
+31% +$1.42K ﹤0.01% 619
2024
Q4 		$5.36K Buy
129
+26
+25% +$1.24K ﹤0.01% 600
2024
Q3 		$6.88K Sell
103
-126
-55% -$11.6K ﹤0.01% 587
2024
Q2 		$27.2K Buy
229
+59
+35% +$7.47K ﹤0.01% 369
2024
Q1 		$18.1K Buy
170
+123
+262% +$12.4K ﹤0.01% 439
2023
Q4 		$4.67K Sell
47
-157
-77% -$13.2K ﹤0.01% 604
2023
Q3 		$21.1K Buy
204
+79
+63% +$8.81K ﹤0.01% 383
2023
Q2 		$15.2K Buy
125
+18
+17% +$2.4K ﹤0.01% 450
2023
Q1 		$16.4K Sell
107
-22
-17% -$3.63K ﹤0.01% 435
2022
Q4 		$23.2K Buy
129
+26
+25% +$4.25K ﹤0.01% 324
2022
Q3 		$12K Buy
103
+18
+21% +$2.73K ﹤0.01% 420
2022
Q2 		$12K Sell
85
-21
-20% -$3K ﹤0.01% 404
2022
Q1 		$18K Buy
106
+24
+29% +$4.04K ﹤0.01% 354
2021
Q4 		$21K Hold
82
– – ﹤0.01% 314
2021
Q3 		$32K Buy
+82
New +$30.2K 0.01% 248

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

MV Capital Management's MRNA Position: Q2 2026 in Review

MV Capital Management increased its Moderna (MRNA) stake by 4.2% in Q2 2026, buying an estimated $259 and bringing the position to 124 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

MV Capital Management first reported a position in MRNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $32K in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MV Capital Management held 124 shares of Moderna worth $8.68K as of Q2 2026.
  • MV Capital Management bought 5 Moderna shares in Q2 2026, an estimated $259.
  • Moderna made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #562 holding.
  • MV Capital Management first reported a position in Moderna in Q3 2021 and has held it in 20 quarters since.
  • MV Capital Management's Moderna position peaked at $32K in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.